Advertisement
UK markets close in 4 hours 43 minutes
  • FTSE 100

    8,066.55
    +42.68 (+0.53%)
     
  • FTSE 250

    19,726.24
    +126.85 (+0.65%)
     
  • AIM

    753.53
    +4.35 (+0.58%)
     
  • GBP/EUR

    1.1587
    -0.0001 (-0.01%)
     
  • GBP/USD

    1.2349
    -0.0001 (-0.01%)
     
  • Bitcoin GBP

    53,688.84
    +202.13 (+0.38%)
     
  • CMC Crypto 200

    1,422.03
    +7.27 (+0.51%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    81.75
    -0.15 (-0.18%)
     
  • GOLD FUTURES

    2,315.90
    -30.50 (-1.30%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,039.97
    +179.17 (+1.00%)
     
  • CAC 40

    8,088.09
    +47.73 (+0.59%)
     

London banker, Canada exec in running for Canaccord CEO post

By Rama Venkat Raman

July 30 (Reuters) - Canadian dealmaker Daniel Daviau and London investment banker Alexis de Rosnay are in the running for the chief executive post at Canaccord Genuity Group Inc, said a source familiar with the matter.

Bloomberg first reported on Thursday that the two were the front-runners for the post and they would present their business plans to the company's board next month. (http://bloom.bg/1DbgXhT)

Daviau is the chief executive of Canaccord's North American capital markets business, while de Rosnay is a former banker whose previous employers include JPMorgan Chase & Co (Xetra: 850628 - news) and Lehman Brothers Holdings Inc.

ADVERTISEMENT

Canaccord said in April that its CEO Paul Reynolds had died, three days after he fell ill while competing in a triathlon in Hawaii.

The company has been hit hard by a combination of tighter regulatory requirements, tougher competition from bank-owned dealers and a slump in activity from resource companies, which have traditionally been the backbone of the Canadian market.

Canaccord's shares closed at C$7.08 on the Toronto Stock Exchange on Wednesday. Up to Wednesday's close, the stock had nearly halved in the past 12 months. (Editing by Kirti Pandey)